Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease

Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki di...

Full description

Saved in:
Bibliographic Details
Published inClinical immunology (Orlando, Fla.) Vol. 171; pp. 25 - 31
Main Authors Ye, Qing, Gong, Fang-qi, Shang, Shi-qiang, Hu, Jian
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. •An imbalance in CD8+ T cell activation and inhibition are important in the pathogenesis of Kawasaki disease.•The percentage of CD8+HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease.•IVIG inhibits CD8+ T cell activation, but if the level of CD8+ T cell activation is too high, IVIG resistance may result.•The ratio of CD3+CD8+HLA-DR+ T cells/CD3+CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.
AbstractList Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.
Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.
Abstract Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4 + and CD8 + T cells during the acute phase of KD. We compared the percentages of HLA-DR +/CD69 +/CD25 + T cells in the CD4 + and CD8 + T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8 + HLA-DR + T cells and the median ratio of CD8 + HLA-DR + T cells/CD8 + CD25 + T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8 + HLA-DR + T cells. There was a significant difference in the ratio of CD8 + HLA-DR + T cells/CD8 + CD69 + T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8 + T cell activation, as well as an imbalance between CD8 + T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8 + HLA-DR + T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8 + T cell activation, but excessive CD8 + T cell activation may cause IVIG resistance. The ratio of CD8 + HLA-DR + T cells/CD8 + CD69 + T cells may be used as a predictor of IVIG sensitivity.
Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. •An imbalance in CD8+ T cell activation and inhibition are important in the pathogenesis of Kawasaki disease.•The percentage of CD8+HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease.•IVIG inhibits CD8+ T cell activation, but if the level of CD8+ T cell activation is too high, IVIG resistance may result.•The ratio of CD3+CD8+HLA-DR+ T cells/CD3+CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.
Author Gong, Fang-qi
Hu, Jian
Ye, Qing
Shang, Shi-qiang
Author_xml – sequence: 1
  givenname: Qing
  surname: Ye
  fullname: Ye, Qing
  organization: Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China
– sequence: 2
  givenname: Fang-qi
  surname: Gong
  fullname: Gong, Fang-qi
  email: gongfangqi63@gmail.com
  organization: Department of Cardiology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China
– sequence: 3
  givenname: Shi-qiang
  surname: Shang
  fullname: Shang, Shi-qiang
  email: qingye@zju.edu.cn
  organization: Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China
– sequence: 4
  givenname: Jian
  surname: Hu
  fullname: Hu, Jian
  organization: Department of Cardiology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27519954$$D View this record in MEDLINE/PubMed
BookMark eNqNkktv1DAUhS1URB_wB1ggL5HQBD9iO2GBVA0UKiqxoKwtx7kpnib2YDtT9d_jdKYbJCpWtqXvHNvn3FN05IMHhF5TUlFC5ftNZUc3VazsK9JUhLJn6IQKRleKcHF02EtJ5TE6TWlDCBGMyRfomClB21bUJ-ju0udoduDDnLCbptmHmzF08-g8zhFMnsBnHCFtg0-ucJAS7mELvk84FOYXlONNBMBhwOtPzTt8jS2MIzY2u53JrkDF65u5M8ncOty7BCbBS_R8MGOCV4f1DP28-Hy9_rq6-v7lcn1-tbJ1zfKqhabnqqHEDKQ2IFlnSU8oqdUwyH4QnAkGteVNX8tO2Y6ZztChpapt6o4Yxc_Q273vNobfM6SsJ5eW9xkP5cuaNlyxVjIu_gcVvFW05QV9c0DnboJeb6ObTLzXj7kWoNkDNoaUIgzauvwQRknbjZoSvVSoN3qpUC8VatLoUmGRsr-kj-5Pij7uRVCy3DmIC-KdNeMt3EPahDn6ErOmOjFN9I9lMpbBoJITVsaiGHz4t4Hug3vq9j_SD8mi
CitedBy_id crossref_primary_10_1093_jpids_piaa162
crossref_primary_10_1186_s12969_020_0420_8
crossref_primary_10_3389_fped_2020_00148
crossref_primary_10_1097_INF_0000000000003144
crossref_primary_10_1186_s12865_018_0282_8
crossref_primary_10_1007_s00246_024_03657_9
crossref_primary_10_3389_fimmu_2024_1457687
crossref_primary_10_1097_BOR_0000000000000447
crossref_primary_10_1016_j_imlet_2024_106948
crossref_primary_10_1016_j_autrev_2020_102554
crossref_primary_10_1038_s41598_021_96632_w
crossref_primary_10_1093_rheumatology_keac250
crossref_primary_10_2147_JIR_S468472
crossref_primary_10_2147_PHMT_S489512
crossref_primary_10_1016_j_cellimm_2022_104554
crossref_primary_10_7717_peerj_4539
crossref_primary_10_1007_s11010_023_04832_x
crossref_primary_10_3389_fimmu_2021_654109
crossref_primary_10_1007_s42399_020_00262_8
crossref_primary_10_2139_ssrn_3937114
crossref_primary_10_1080_03009742_2019_1604992
crossref_primary_10_3389_fimmu_2020_01660
crossref_primary_10_3389_fimmu_2019_01156
crossref_primary_10_1002_bies_202100256
crossref_primary_10_1186_s12865_021_00407_x
crossref_primary_10_3389_fimmu_2018_01892
crossref_primary_10_3389_fmolb_2023_1182512
crossref_primary_10_1038_nrrheum_2016_146
crossref_primary_10_1016_j_intimp_2021_108396
Cites_doi 10.1371/journal.pgen.1000319
10.1136/heartjnl-2015-307734
10.2741/2096
10.1136/archdischild-2014-307536
10.1155/2012/935425
10.1016/j.autrev.2015.11.010
10.4049/jimmunol.155.3.1151
10.1016/S0065-2776(08)60801-9
10.1086/323155
10.1056/NEJMp068268
10.1016/0046-8177(90)90135-R
10.1002/art.39112
10.1002/art.37815
10.1002/(SICI)1097-0320(19990615)38:3<95::AID-CYTO1>3.0.CO;2-L
10.2169/internalmedicine.52.9463
10.1016/S1568-9972(02)00065-4
10.1038/sj.gene.6364225
10.1182/blood-2003-04-1320
10.1161/CIRCULATIONAHA.107.751404
10.1038/pr.2015.12
ContentType Journal Article
Copyright 2016
Copyright © 2016. Published by Elsevier Inc.
Copyright_xml – notice: 2016
– notice: Copyright © 2016. Published by Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
DOI 10.1016/j.clim.2016.08.012
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE
MEDLINE - Academic


AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1521-7035
EndPage 31
ExternalDocumentID 27519954
10_1016_j_clim_2016_08_012
1_s2_0_S1521661616302005
S1521661616302005
Genre Clinical Trial
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABPPZ
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HX~
HZ~
IH2
IHE
J1W
K-O
KOM
L7B
LG5
LUGTX
M41
MO0
N9A
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSZ
T5K
X7M
XPP
Y6R
Z5R
ZGI
ZMT
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
SSI
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
ID FETCH-LOGICAL-c442t-9e8d37810af04ae62bc0d01047ff6df53252e4c38d46b7cb2aba1f917984b0a73
ISSN 1521-6616
1521-7035
IngestDate Fri Jul 11 06:40:41 EDT 2025
Fri Jul 11 04:51:57 EDT 2025
Mon Jul 21 05:53:44 EDT 2025
Thu Apr 24 23:00:52 EDT 2025
Tue Jul 01 02:44:03 EDT 2025
Tue Feb 25 20:03:49 EST 2025
Tue Aug 26 16:33:56 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Flow cytometry
Immune activation
Kawasaki disease
ROC curve
CD8+HLA-DR+ T cells
CD8 + HLA-DR + T cells
Language English
License Copyright © 2016. Published by Elsevier Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c442t-9e8d37810af04ae62bc0d01047ff6df53252e4c38d46b7cb2aba1f917984b0a73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 27519954
PQID 1835397193
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1837296235
proquest_miscellaneous_1835397193
pubmed_primary_27519954
crossref_citationtrail_10_1016_j_clim_2016_08_012
crossref_primary_10_1016_j_clim_2016_08_012
elsevier_clinicalkeyesjournals_1_s2_0_S1521661616302005
elsevier_clinicalkey_doi_10_1016_j_clim_2016_08_012
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-10-01
PublicationDateYYYYMMDD 2016-10-01
PublicationDate_xml – month: 10
  year: 2016
  text: 2016-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical immunology (Orlando, Fla.)
PublicationTitleAlternate Clin Immunol
PublicationYear 2016
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Brown, Crawford, Cornwall, Garcia, Shulman, Rowley (bb0080) 2001; 184
Cosmi, Liotta, Lazzeri, Francalanci, Angeli, Mazzinghi (bb0105) 2003; 102
Rutella, Rumi, Lucia, Barberi, Puggioni, Lai (bb0125) 1999; 38
Burns, Shimizu, Shike, Newburger, Sundel, Baker (bb0055) 2005; 6
Starska, Glowacka, Kulig, Lewy-Trenda, Brys, Lewkowicz (bb0075) 2011; 49
Ohmoto-Sekine, Ishihara, Hsieh, Amakawa, Hara, Tsuji (bb0020) 2013; 52
Kawasaki (bb0005) 1967; 16
Filaci, Suciu-Foca (bb0115) 2002; 1
Fraison, Seve, Dauphin, Mahr, Gomard-Mennesson, Varron (bb0025) 2016; 15
Hartopo, Setianto (bb0030) 2013; 45
Keckler (bb0095) 2007; 12
Baker, Newburger (bb0015) 2008; 118
Burns (bb0045) 2007; 356
Sugawara (bb0085) 1991; 40
Tincati, Bellistri, Ancona, Merlini, Monforte, Marchetti (bb0070) 2012; 2012
Sakaguchi, Sakaguchi, Asano, Itoh, Toda (bb0100) 1995; 155
Ye, Shao, Shang, Zhang, Hu, Zhang (bb0035) 2015; 67
Singh, Vignesh, Burgner (bb0010) 2015; 100
Terai, Kohno, Namba, Umemiya, Niwa, Nakajima (bb0090) 1990; 21
Burgner, Davila, Breunis, Ng, Li, Bonnard (bb0050) 2009; 5
Bienvenu, Martin, Auffray, Cordier, Becourt, Lucas (bb0110) 1950; 175
Wakiguchi, Hasegawa, Suzuki, Kudo, Ichiyama (bb0120) 2015; 77
Shah, Christov, Mukasa, Brogan, Wade, Eleftheriou (bb0060) 2015; 101
Winchester, Kunkel (bb0065) 1979; 28
Wang, Wang, Gong, Fu, Zhang, Hu (bb0040) 2013; 65
Ohmoto-Sekine (10.1016/j.clim.2016.08.012_bb0020) 2013; 52
Wang (10.1016/j.clim.2016.08.012_bb0040) 2013; 65
Burns (10.1016/j.clim.2016.08.012_bb0045) 2007; 356
Hartopo (10.1016/j.clim.2016.08.012_bb0030) 2013; 45
Shah (10.1016/j.clim.2016.08.012_bb0060) 2015; 101
Baker (10.1016/j.clim.2016.08.012_bb0015) 2008; 118
Cosmi (10.1016/j.clim.2016.08.012_bb0105) 2003; 102
Wakiguchi (10.1016/j.clim.2016.08.012_bb0120) 2015; 77
Filaci (10.1016/j.clim.2016.08.012_bb0115) 2002; 1
Starska (10.1016/j.clim.2016.08.012_bb0075) 2011; 49
Burgner (10.1016/j.clim.2016.08.012_bb0050) 2009; 5
Winchester (10.1016/j.clim.2016.08.012_bb0065) 1979; 28
Brown (10.1016/j.clim.2016.08.012_bb0080) 2001; 184
Singh (10.1016/j.clim.2016.08.012_bb0010) 2015; 100
Ye (10.1016/j.clim.2016.08.012_bb0035) 2015; 67
Kawasaki (10.1016/j.clim.2016.08.012_bb0005) 1967; 16
Sakaguchi (10.1016/j.clim.2016.08.012_bb0100) 1995; 155
Terai (10.1016/j.clim.2016.08.012_bb0090) 1990; 21
Sugawara (10.1016/j.clim.2016.08.012_bb0085) 1991; 40
Keckler (10.1016/j.clim.2016.08.012_bb0095) 2007; 12
Rutella (10.1016/j.clim.2016.08.012_bb0125) 1999; 38
Fraison (10.1016/j.clim.2016.08.012_bb0025) 2016; 15
Burns (10.1016/j.clim.2016.08.012_bb0055) 2005; 6
Tincati (10.1016/j.clim.2016.08.012_bb0070) 2012; 2012
Bienvenu (10.1016/j.clim.2016.08.012_bb0110) 1950; 175
27558657 - Nat Rev Rheumatol. 2016 Oct;12(10):562
References_xml – volume: 67
  start-page: 1943
  year: 2015
  end-page: 1950
  ident: bb0035
  article-title: A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease
  publication-title: Arthritis Rheum. (Hoboken, N.J.)
– volume: 5
  year: 2009
  ident: bb0050
  article-title: A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease
  publication-title: PLoS Genet.
– volume: 155
  start-page: 1151
  year: 1995
  end-page: 1164
  ident: bb0100
  article-title: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
  publication-title: J. Immunol. (Baltimore, Md.: 1950)
– volume: 356
  start-page: 659
  year: 2007
  end-page: 661
  ident: bb0045
  article-title: The riddle of Kawasaki disease
  publication-title: N. Engl. J. Med.
– volume: 21
  start-page: 231
  year: 1990
  end-page: 234
  ident: bb0090
  article-title: Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease
  publication-title: Hum. Pathol.
– volume: 40
  start-page: 476
  year: 1991
  end-page: 482
  ident: bb0085
  article-title: Immunopathology of skin lesions in Kawasaki disease
  publication-title: Arerugi
– volume: 49
  start-page: 579
  year: 2011
  end-page: 592
  ident: bb0075
  article-title: The role of tumor cells in the modification of T lymphocytes activity–the expression of the early CD69
  publication-title: Part I, Folia histochemica et cytobiologica/Polish Academy of Sciences
– volume: 45
  start-page: 69
  year: 2013
  end-page: 75
  ident: bb0030
  article-title: Coronary artery sequel of Kawasaki disease in adulthood, a concern for internists and cardiologists
  publication-title: Acta Medica Indonesiana
– volume: 38
  start-page: 95
  year: 1999
  end-page: 101
  ident: bb0125
  article-title: Induction of CD69 antigen on normal CD4
  publication-title: Cytometry
– volume: 175
  start-page: 246
  year: 1950
  end-page: 253
  ident: bb0110
  article-title: Peripheral CD8
  publication-title: J. Immunol. (Baltimore: Md.
– volume: 1
  start-page: 279
  year: 2002
  end-page: 283
  ident: bb0115
  article-title: CD8
  publication-title: Autoimmun. Rev.
– volume: 100
  start-page: 1084
  year: 2015
  end-page: 1088
  ident: bb0010
  article-title: The epidemiology of Kawasaki disease: a global update
  publication-title: Arch. Dis. Child.
– volume: 15
  start-page: 242
  year: 2016
  end-page: 249
  ident: bb0025
  article-title: Kawasaki disease in adults: observations in France and literature review
  publication-title: Autoimmun. Rev.
– volume: 2012
  start-page: 935425
  year: 2012
  ident: bb0070
  article-title: Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients
  publication-title: Clin. Dev. Immunol.
– volume: 118
  start-page: e110
  year: 2008
  end-page: e112
  ident: bb0015
  article-title: Cardiology patient pages. Kawasaki disease
  publication-title: Circulation
– volume: 77
  start-page: 536
  year: 2015
  end-page: 540
  ident: bb0120
  article-title: Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease
  publication-title: Pediatr. Res.
– volume: 101
  start-page: 1646
  year: 2015
  end-page: 1655
  ident: bb0060
  article-title: Cardiovascular status after Kawasaki disease in the UK
  publication-title: Heart
– volume: 12
  start-page: 725
  year: 2007
  end-page: 732
  ident: bb0095
  article-title: Dodging the CTL response: viral evasion of Fas and granzyme induced apoptosis
  publication-title: Front. Biosci.
– volume: 65
  start-page: 805
  year: 2013
  end-page: 814
  ident: bb0040
  article-title: Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease
  publication-title: Arthritis Rheum.
– volume: 28
  start-page: 221
  year: 1979
  end-page: 292
  ident: bb0065
  article-title: The human Ia system
  publication-title: Adv. Immunol.
– volume: 52
  start-page: 977
  year: 2013
  end-page: 980
  ident: bb0020
  article-title: Giant coronary artery aneurysms associated with Kawasaki disease detected on whole-heart magnetic resonance coronary angiographic screening
  publication-title: Intern. Med. (Tokyo, Japan)
– volume: 184
  start-page: 940
  year: 2001
  end-page: 943
  ident: bb0080
  article-title: CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease
  publication-title: J. Infect. Dis.
– volume: 16
  start-page: 178
  year: 1967
  end-page: 222
  ident: bb0005
  article-title: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children
  publication-title: Arerugi
– volume: 102
  start-page: 4107
  year: 2003
  end-page: 4114
  ident: bb0105
  article-title: Human CD8
  publication-title: Blood
– volume: 6
  start-page: 438
  year: 2005
  end-page: 444
  ident: bb0055
  article-title: Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease
  publication-title: Genes Immun.
– volume: 5
  year: 2009
  ident: 10.1016/j.clim.2016.08.012_bb0050
  article-title: A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1000319
– volume: 101
  start-page: 1646
  year: 2015
  ident: 10.1016/j.clim.2016.08.012_bb0060
  article-title: Cardiovascular status after Kawasaki disease in the UK
  publication-title: Heart
  doi: 10.1136/heartjnl-2015-307734
– volume: 45
  start-page: 69
  year: 2013
  ident: 10.1016/j.clim.2016.08.012_bb0030
  article-title: Coronary artery sequel of Kawasaki disease in adulthood, a concern for internists and cardiologists
  publication-title: Acta Medica Indonesiana
– volume: 12
  start-page: 725
  year: 2007
  ident: 10.1016/j.clim.2016.08.012_bb0095
  article-title: Dodging the CTL response: viral evasion of Fas and granzyme induced apoptosis
  publication-title: Front. Biosci.
  doi: 10.2741/2096
– volume: 49
  start-page: 579
  year: 2011
  ident: 10.1016/j.clim.2016.08.012_bb0075
  article-title: The role of tumor cells in the modification of T lymphocytes activity–the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma
– volume: 100
  start-page: 1084
  year: 2015
  ident: 10.1016/j.clim.2016.08.012_bb0010
  article-title: The epidemiology of Kawasaki disease: a global update
  publication-title: Arch. Dis. Child.
  doi: 10.1136/archdischild-2014-307536
– volume: 2012
  start-page: 935425
  year: 2012
  ident: 10.1016/j.clim.2016.08.012_bb0070
  article-title: Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2012/935425
– volume: 15
  start-page: 242
  year: 2016
  ident: 10.1016/j.clim.2016.08.012_bb0025
  article-title: Kawasaki disease in adults: observations in France and literature review
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2015.11.010
– volume: 155
  start-page: 1151
  year: 1995
  ident: 10.1016/j.clim.2016.08.012_bb0100
  article-title: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
  publication-title: J. Immunol. (Baltimore, Md.: 1950)
  doi: 10.4049/jimmunol.155.3.1151
– volume: 28
  start-page: 221
  year: 1979
  ident: 10.1016/j.clim.2016.08.012_bb0065
  article-title: The human Ia system
  publication-title: Adv. Immunol.
  doi: 10.1016/S0065-2776(08)60801-9
– volume: 184
  start-page: 940
  year: 2001
  ident: 10.1016/j.clim.2016.08.012_bb0080
  article-title: CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease
  publication-title: J. Infect. Dis.
  doi: 10.1086/323155
– volume: 356
  start-page: 659
  year: 2007
  ident: 10.1016/j.clim.2016.08.012_bb0045
  article-title: The riddle of Kawasaki disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp068268
– volume: 21
  start-page: 231
  year: 1990
  ident: 10.1016/j.clim.2016.08.012_bb0090
  article-title: Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease
  publication-title: Hum. Pathol.
  doi: 10.1016/0046-8177(90)90135-R
– volume: 67
  start-page: 1943
  year: 2015
  ident: 10.1016/j.clim.2016.08.012_bb0035
  article-title: A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease
  publication-title: Arthritis Rheum. (Hoboken, N.J.)
  doi: 10.1002/art.39112
– volume: 65
  start-page: 805
  year: 2013
  ident: 10.1016/j.clim.2016.08.012_bb0040
  article-title: Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.37815
– volume: 175
  start-page: 246
  issue: 2005
  year: 1950
  ident: 10.1016/j.clim.2016.08.012_bb0110
  article-title: Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity
  publication-title: J. Immunol. (Baltimore: Md.
– volume: 16
  start-page: 178
  year: 1967
  ident: 10.1016/j.clim.2016.08.012_bb0005
  article-title: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children
  publication-title: Arerugi=[Allergy]
– volume: 38
  start-page: 95
  year: 1999
  ident: 10.1016/j.clim.2016.08.012_bb0125
  article-title: Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells
  publication-title: Cytometry
  doi: 10.1002/(SICI)1097-0320(19990615)38:3<95::AID-CYTO1>3.0.CO;2-L
– volume: 52
  start-page: 977
  year: 2013
  ident: 10.1016/j.clim.2016.08.012_bb0020
  article-title: Giant coronary artery aneurysms associated with Kawasaki disease detected on whole-heart magnetic resonance coronary angiographic screening
  publication-title: Intern. Med. (Tokyo, Japan)
  doi: 10.2169/internalmedicine.52.9463
– volume: 40
  start-page: 476
  year: 1991
  ident: 10.1016/j.clim.2016.08.012_bb0085
  article-title: Immunopathology of skin lesions in Kawasaki disease
  publication-title: Arerugi=[Allergy]
– volume: 1
  start-page: 279
  year: 2002
  ident: 10.1016/j.clim.2016.08.012_bb0115
  article-title: CD8+ T suppressor cells are back to the game: are they players in autoimmunity?
  publication-title: Autoimmun. Rev.
  doi: 10.1016/S1568-9972(02)00065-4
– volume: 6
  start-page: 438
  year: 2005
  ident: 10.1016/j.clim.2016.08.012_bb0055
  article-title: Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease
  publication-title: Genes Immun.
  doi: 10.1038/sj.gene.6364225
– volume: 102
  start-page: 4107
  year: 2003
  ident: 10.1016/j.clim.2016.08.012_bb0105
  article-title: Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes
  publication-title: Blood
  doi: 10.1182/blood-2003-04-1320
– volume: 118
  start-page: e110
  year: 2008
  ident: 10.1016/j.clim.2016.08.012_bb0015
  article-title: Cardiology patient pages. Kawasaki disease
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.751404
– volume: 77
  start-page: 536
  year: 2015
  ident: 10.1016/j.clim.2016.08.012_bb0120
  article-title: Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease
  publication-title: Pediatr. Res.
  doi: 10.1038/pr.2015.12
– reference: 27558657 - Nat Rev Rheumatol. 2016 Oct;12(10):562
SSID ssj0005226
Score 2.3235395
Snippet Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults....
Abstract Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 25
SubjectTerms Allergy and Immunology
CD4-Positive T-Lymphocytes - immunology
CD8 + HLA-DR + T cells
CD8-Positive T-Lymphocytes - immunology
Child
Child, Preschool
Female
Flow cytometry
Humans
Immune activation
Immunoglobulins, Intravenous - pharmacology
Immunoglobulins, Intravenous - therapeutic use
Immunologic Factors - pharmacology
Immunologic Factors - therapeutic use
Infant
Kawasaki disease
Lymphocyte Activation
Male
Mucocutaneous Lymph Node Syndrome - drug therapy
Mucocutaneous Lymph Node Syndrome - immunology
ROC curve
T-Lymphocyte Subsets - immunology
Treatment Outcome
Title Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1521661616302005
https://www.clinicalkey.es/playcontent/1-s2.0-S1521661616302005
https://www.ncbi.nlm.nih.gov/pubmed/27519954
https://www.proquest.com/docview/1835397193
https://www.proquest.com/docview/1837296235
Volume 171
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5FRUJcEG_CS4sEp8iRvV6vnSMUogAqEiKVymm1L9NUUQJNQiUOnPnZzL4cm7YR9BIlltePzOfZmc8z3yL0oqAkrXOWJVVByoQakydiJPJEa4h3NaGVcgKmBx_Z5JC-PyqOer3fraqlzVoO1c8L-0quYlXYBna1XbL_YdnmoLABvoN94RMsDJ__ZON3lpn94VVWZ7bRY2n1PVxt-baA_DRUwQav5le9jS8J4Cck3I432H9TvSSvB9OB5fKdxoZnay0j8kGciRXEmp33OVHfIPZW-itwkk5Ww9R1ETsidjwXwxbj8MVxqJ_inOnE-b3HGYvF1-T7rGF9GjL7eAabxXbAZOPQF6EdWIuMNfVvgUqL7TSdak8bSyQQMLCOe_ZLtEQHW7Smaj9_nJsEPB9xMlTzmdUayJgTaQ3V2l1x7c_2lPaMEJamXgz3GoGEw3rM4a92sZBbuK-5wNB-5SsF_z7PZSHOZSmMC2Wmt9DNkIPgVx5Qt1HPLO6g6wehyuIuOmvhCndxhRtc4S6ucMAVXsI-xwZ7XOFljQFXAzzFFlV4iyoMx4qowgFV99Dh-O10f5KEBToSRSlZJyNT6bysslTUKRWGEalS7QSf6prpushJQQxVeaUpk6WSREiR1SOrkUdlKsr8PtpbLBfmIcJMyNRArCp0SajKiKyrvFJSF6xWekRMH2XxP-UqqNfbRVTmPJYpnnBrB27twO3Kqhnpo0Ez5pvXbtm5dx5NxWNXMsyjHFC1c1R50SizCm5ixTO-Ijzl55DWR88jHji4dGsFsTBgWA6zbAFpAqRWO_eBtBhyFzjOAw-m5h5JWVjhBfroSnf0GN3YPrBP0N76dGOeQuC9ls_cM_EH77zYvw
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intravenous+immunoglobulin+treatment+responsiveness+depends+on+the+degree+of+CD8%2B+T+cell+activation+in+Kawasaki+disease&rft.jtitle=Clinical+immunology+%28Orlando%2C+Fla.%29&rft.au=Ye%2C+Qing&rft.au=Gong%2C+Fang-qi&rft.au=Shang%2C+Shi-qiang&rft.au=Hu%2C+Jian&rft.date=2016-10-01&rft.pub=Elsevier+Inc&rft.issn=1521-6616&rft.volume=171&rft.spage=25&rft.epage=31&rft_id=info:doi/10.1016%2Fj.clim.2016.08.012&rft.externalDocID=S1521661616302005
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6616&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6616&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6616&client=summon